These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 805176)

  • 1. Immunosuppression induced in vitro by mastocytoma tumor cells and cell-free extracts.
    Kamo I; Patel C; Kateley J; Friedman H
    J Immunol; 1975 Jun; 114(6):1749-56. PubMed ID: 805176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of in vitro immune responsiveness of mastocytoma-suppressed splenocytes by activated T cells.
    Kamo I; Patel C; Patel N; Friedman H
    J Immunol; 1975 Aug; 115(2):382-6. PubMed ID: 807635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. II. Lack of antigenic specificity and immunogenetic requirements of allogeneic suppressive factor (ASF).
    Yonkosky D; Buffett RF; Bennett M
    J Immunol; 1976 Jun; 116(6):1695-703. PubMed ID: 58047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mastocytoma-induced suppression of in vitro antibody formation.
    Kamo I; Kateley J; Freidman H
    Proc Soc Exp Biol Med; 1975 Mar; 148(3):883-6. PubMed ID: 805435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential immunosuppressive effects of ascites fluid from mastocytoma-bearing mice on primary vs secondary immunocyte responses.
    Kamo I; Friedman H
    J Immunol; 1978 Feb; 120(2):558-62. PubMed ID: 413868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the immune response in vitro and in vivo by splenocytes from tumor-bearing mice.
    Specter SC; Kamo I; Friedman H
    Adv Exp Med Biol; 1976; 66():457-63. PubMed ID: 817575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potentiality of antibody-producing cells. I Bispecific cell occurrence in double stimulated cultures of syngeneic or allogeneic spleen cells of the mouse.
    Couderc J; Bleux C; Birrien JL; Liacopoulos P
    Immunology; 1975 Oct; 29(4):653-64. PubMed ID: 1102444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of mastocytoma-mediated suppression of lymphocyte reactivity.
    DeLustro F; Argyris BF
    J Immunol; 1976 Dec; 117(6):2073-80. PubMed ID: 136473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo immune response suppression by the supernatant from concanavalin A-activated spleen cells.
    Reinertsen JL; Steinberg AD
    J Immunol; 1977 Jul; 119(1):217-22. PubMed ID: 326957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.
    Igarashi T; Okada M; Kishimoto S; Yamamura Y
    Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. I. Allogeneic suppressive factor (ASF) from spleens repopulated with thymus cells.
    Yonkosky D; Buffett RF; Bennett M
    J Immunol; 1976 Jun; 116(6):1688-94. PubMed ID: 58046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Nonspecific" immunoenhancing T cells in tumor-bearing mice include anti-idiotypic subsets.
    Behforouz N; Eardley DD; Cerny J
    J Immunol; 1983 Nov; 131(5):2576-9. PubMed ID: 6226744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of suppressor cells in mice bearing syngeneic mastocytoma.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1977 Feb; 118(2):412-7. PubMed ID: 65423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-induced immunosuppression.
    Friedman H; Specter S; Watanabe M; Pan SH
    Am J Pathol; 1978 Nov; 93(2):499-514. PubMed ID: 102206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloma-induced immunosuppression: a multistep mechanism.
    Katzmann JA
    J Immunol; 1978 Oct; 121(4):1405-9. PubMed ID: 701801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of the antibody response to SRBC with F(ab') 2 and IgG in vitro.
    Wason WM; Fitch FW
    J Immunol; 1973 May; 110(5):1427-9. PubMed ID: 4572635
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of humoral factors of the mastocytoma P815 cells on the formation of allospecific killers in mixed culture of lymphocytes and their cytotoxic activity].
    Medvedev AE; Dostman U; Flegel' A
    Biull Eksp Biol Med; 1989 Aug; 108(8):224-6. PubMed ID: 2529921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
    Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
    Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-specific suppression of the initiation of the immune response to a heterologous immunogen by supernatants from specifically stimulated, primed lymphoid cells.
    Douglas GN; Rubin AS
    Immunology; 1977 May; 32(5):669-79. PubMed ID: 324897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.